S. Sharma et al., GASTROINTESTINAL COMPLICATIONS AFTER ORTHOTOPIC CARDIAC TRANSPLANTATION, European journal of cardio-thoracic surgery, 10(8), 1996, pp. 616-620
Objective and methods. A retrospective chart review was performed on a
ll patients undergoing orthotopic cardiac allograft transplant at Oreg
on Health Sciences University. Our purpose was to evaluate the inciden
ce of gastrointestinal complications in these patients, and to assess
the effect of immunosuppression.Results. From December, 1985, to June,
1994, 240 recipients underwent 250 orthotopic cardiac allograft trans
plants at Oregon Health Sciences University with a 30 day mortality of
15 patients (6.3 +/- 3.0%). Of the 225 operative survivors, the follo
w-up ranges from 1.0 month to 8.8 years with a mean of 39.9 +/- 1.9 mo
nths. In our population of late survivors, 21 recipients (9.3%) have h
ad gastrointestinal complications (GIC). Hepatobiliary (29%), peptic u
lcer (14%), and pancreatic (14%) complications were the most prevalent
. Surgical intervention was required in 19 patients (90%). Twelve proc
edures (63%) were either emergently or urgently performed, and seven p
rocedures (37%) carried out electively. Operative mortality was 33% in
those patients with an emergent or urgent intervention. There was no
operative mortality among those who had an elective procedure. Conclus
ion. Maintenance prednisone dose was higher in patients with GIC than
in those patients without GIC, 16.1 +/- 2.5 mg versus 7.3 +/- 0.2 mg (
P = 0.001), respectively. However, immunosuppression therapy for rejec
tion episodes (i.e., Solumedrol megapulse or OKT3 therapy) was not rel
ated to an increased incidence of GIC. We present a review of our 21 c
ardiac transplant recipients to emphasize the potential for severe GIC
and their corresponding perioperative morbidity and mortality.